Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diffuse Intrinsic Pontine Glioma × Pharmacogenomic Testing × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Leukemia, Lymphocytic, Chronic, B-Cell 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Mantle-Cell 6 Lymphoma, B-Cell, Marginal Zone 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Follicular 5 Colorectal Neoplasms 5 Waldenstrom Macroglobulinemia 4 Unspecified Adult Solid Tumor, Protocol Specific 4 Rectal Neoplasms 4 Pancreatic Neoplasms 4 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, Extranodal NK-T-Cell 4 Lymphoma 4 Leukemia, Prolymphocytic 4 Leukemia 4 Hodgkin Disease 4 Carcinoma, Hepatocellular 4 Burkitt Lymphoma 4 Squamous Cell Carcinoma of Head and Neck 3 Sezary Syndrome 3 Neoplasms 3 Mycosis Fungoides 3 Multiple Myeloma 3 Lymphoma, Large-Cell, Anaplastic 3 Leukemia, Myeloid, Acute 3

Interventions

Temozolomide 15 Radiotherapy 10 Bevacizumab 6 Irinotecan 5 Everolimus 5 Cyclophosphamide 5 ribociclib 4 Radiation 4 TIC10 compound 3 Re-Irradiation 3 Panobinostat 3 Etoposide 3 Dasatinib 3 pembrolizumab 2 nimotuzumab 2 abemaciclib 2 Vorinostat 2 Valproic Acid 2 Topotecan 2 Specimen Handling 2 Nivolumab 2 Mebendazole 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 GDC-0084 2 Erlotinib Hydrochloride 2 Diphtheria-Tetanus Vaccine 2 Cilengitide 2 Cetuximab 2 1-methyltryptophan 2 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01165333 2026-03-16

CILENT

Centre Oscar Lambret

Phase 1 Completed

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡